Delivery Order SPE2DB22D3016-SPE2DB25FBGR3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,588.31 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This is a firm fixed-price delivery order with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a ceiling value of $2,247.57. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,139.11 and employs firm fixed-price pricing. The delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment. This firm fixed price delivery order, valued at $2,475.20, represents a non-set-aside competitive award and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,368.29 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, awarded on June 3, 2025, with completion targeted for June 4, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a delivery order valued at $5,213.92 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,960.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.80 to AmerisourceBergen Drug Corp for erythromycin 0.5% eye ointment, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger pharmaceutical supply relationship with DLA....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGR3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,945.13 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed price contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order is classified as a child contract, indicating it derives from a larger prime contract or indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this requirement under its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies the routine but essential pharmaceutical procurement that occurs under such master contracts, supporting the Defense Health Agency and other federal healthcare systems' operational medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/28/25 |